202. Genetics of Retinoblastoma – David Cobrinik

203. Diagnosis of Retinoblastoma – Christina Stathopoulos

204. Conservative management of retinoblastoma – Francis Munier

205. Role of liquid biopsies – Jesse Berry

207. RB challenges around the world – Oncopediatric view  – Guillermo Chantada

208. GRAACC and the Oncopediatric care – Carla Macedo

209. GRAACC and the Brazilian experience in RB – Luiz Fernando Teixeira

210. De Olho nos Olhinhos – Daiana Garbin Leifert e Tiago Leifert

212. Study of Information Available About Leukocoria and Retinoblastoma to Information-Seeking Parents on ChatGPT and AI Apps – Ashwin Mallipatna

213. SWIMMERRB: Objective Research Outcome Assessment Tool for Retinoblastoma – Brenda Gallie

215. Retinoblastoma Origins and Trajectories – David Cobrinik

217. – Rescue of Retinal Function in a Child with ACBD5 associated Syndromic Retinal Dystrophy after Hematopoetic Stem Cell Transplant – Ken K. Nischal

218. – Development and subretinal delivery of a novel MiR-181 inhibitor in rat – Lorena de Melo Haefeli

219. – SLC24A1-related Retinal Dystrophy: Report of a Novel Nonsense Variant associated with Congenital Stationary Night Blindness – Hannah L. Scanga

220. – A rare mutation of SLC52A2 gene – Maja Kostic

221. – Evaluating Visual Photosensitivity in Subjects with and without Achromatopsia using the Ocular Photosensitivity Analyzer and the VLSQ-8 Questionnaire – Byron L. Lam

222. – Ph1/2 AAV5-RPGR (Botaretigene Sparoparvovec) Gene Therapy Trial in RPGR-associated X-linked Retinitis Pigmentosa (XLRP) – Rachel Huckfeldt

223. – PRODYGY: Study Design of a First-in-Human Trial of SPVN06 Gene-Independent Gene Therapy in Subjects with Rod-Cone Dystrophy – Daniel C Chung

224. – Mild RPE65-related inherited retinal disease (IRD) associated with novel putatively hypomorphic variant – Filip Van den Broeck

225. – Variants of RPE65 in patients of Leber’s congenital Amaurosis in Argentina – Marcela Ciccioli

227. – Grand Rounds – Case Presentation – Rene Moya

228. – Grand Rounds – Case Presentation – Huber Vasconcelos

229. – Grand Rounds – Case Presentation – Laura Echandi

230. – Grand Rounds – Case Presentation – Alejandra Antacle

231. – Grand Rounds – Case Presentation – Maria Balen Yadarola

232. – Grand Rounds – Case Presentation – Maja Kostic

233. – Grand Rounds – Case Presentation – Byron Lam

2AB 202 – Deficiência Visual – Inovações para Acessibilidade e Inclusão (Português)

Welcome to Patient associations – Maria Julia da Silva Araujo, Roseli de Souza Oliveira and Christina Fasser
Retina São Paulo – Roseli de Souza Oliveira
Retina Brasil – Angela Sousa
Fundación Lucha contra la Retinitis Pigmentosa (Fundalurp) Chile – Gustavo Serrano
Fundacion Argentina de Retinosis Pigmentaria– Francisco Albarracin
Asociación Es Retina Asturias – Andres Mayor Lorenzo
Stargardt Apnes – Marcela Ciccioli
Grupo Stargardt – Marina Leite
Choroideremia Research Foundation – Eric Hartman
Curing Retinal Blindness Foundation CRB1 – Kristin Smedley
RDH12 Fund for Sight – Cecilia Vasconcelos
Foundation Fighting Blindness – Rachel Huckfeldt
Retina Internacional – Christina Fasser
Building connections

2AB 204. Evaluation of the outcomes of intravitreal chemotherapy for retinoblastoma in a referral center in Argentina – Claudia Sampor

2AB 205. GALOP II protocol for the treatment of unilateral non-metastatic retinoblastoma – preliminary results in a referal center in Argentina – Claudia Sampor

2AB 206. Orbital pharmacokinetics of topotecan after ophthalmic artery chemosurgery in pigs: significance in high-risk locally disseminated retinoblastoma therapy – Alan Andres Vater

2AB 207. Gemcitabine as a potential new drug for retinoblastoma treatment – Maria Belen Cancela

2AB 208. Evaluation of Visual Outcomes in Retinoblastoma Survivors and Determining Factors Predicting Failure of Vision Salvage – Ashwin Mallipatna

2AB 209. Management and outcome of retinoblastoma with no optic nerve head following first line therapy – Christina Stathopoulos

2AB 210. Clinical presentation and outcome of retinoblastoma in older children – Luiz Fernando Teixeira

2AB 211. Retinoblastoma in Chile 2022 – Results of the National Multi-Center Study – Diego Ossandon

2AB 212. Panel discussion: RB and the future perspectives – Francis Munier and Maja Beck-Popovic